Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 1,089 Shares of Stock
Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,089 shares of the stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $108.19, for a total transaction of $117,818.91. Following the sale, the executive vice president now directly owns 27,751 shares of the company’s stock, valued at $3,002,380.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of Varian Medical Systems, Inc. (VAR) traded down $0.41 during trading on Tuesday, hitting $108.08. 997,513 shares of the company traded hands, compared to its average volume of 780,090. The stock has a market cap of $9,900.00, a price-to-earnings ratio of 39.16, a P/E/G ratio of 3.30 and a beta of 0.68. Varian Medical Systems, Inc. has a 52-week low of $76.94 and a 52-week high of $114.09.
Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.19 by ($0.10). The company had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The business’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 earnings per share. sell-side analysts forecast that Varian Medical Systems, Inc. will post 4.11 EPS for the current fiscal year.
Several analysts have commented on VAR shares. Zacks Investment Research lowered shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Citigroup increased their price target on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research report on Monday, October 30th. Royal Bank of Canada set a $105.00 price objective on shares of Varian Medical Systems and gave the company a “hold” rating in a research report on Thursday, November 30th. Finally, Evercore ISI initiated coverage on shares of Varian Medical Systems in a research report on Wednesday, January 3rd. They issued an “underperform” rating and a $100.00 price objective for the company. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $100.44.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.